W

Waystar Holding Corp
NASDAQ:WAY

Watchlist Manager
Waystar Holding Corp
NASDAQ:WAY
Watchlist
Price: 36.785 USD -0.1%
Market Cap: 6.3B USD
Have any thoughts about
Waystar Holding Corp?
Write Note

Waystar Holding Corp
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Waystar Holding Corp
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
W
Waystar Holding Corp
NASDAQ:WAY
Research & Development
-$35.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Research & Development
-$675.1m
CAGR 3-Years
-23%
CAGR 5-Years
-29%
CAGR 10-Years
-34%
Inspire Medical Systems Inc
NYSE:INSP
Research & Development
-$114.8m
CAGR 3-Years
-49%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Research & Development
-$82m
CAGR 3-Years
-23%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Research & Development
-$87.5m
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
-12%
Certara Inc
NASDAQ:CERT
Research & Development
-$34.2m
CAGR 3-Years
-20%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
No Stocks Found

Waystar Holding Corp
Glance View

Market Cap
6.3B USD
Industry
Health Care

Waystar Holding Corp. sits at the intersection of healthcare and technology, quietly revolutionizing the financial infrastructure of the medical industry. Born from a merger of two industry stalwarts, Navicure and ZirMed, Waystar has gained a reputation for offering comprehensive revenue cycle management solutions. The company's primary mission is to simplify and streamline the healthcare reimbursement process, an area historically fraught with complexity and inefficiency. By leveraging advanced cloud-based technology and a suite of intelligent tools, Waystar enables healthcare providers to process claims, track payments, and manage denials with unprecedented efficiency, thus reducing administrative costs and improving financial outcomes. Financially, Waystar thrives by licensing its innovative platform to a broad range of healthcare providers, from sprawling hospital systems to smaller clinics and physician groups. These subscriptions are often based on the scale and complexity of the healthcare entities' needs, providing Waystar with a steady stream of predictable revenue. Additionally, the company capitalizes on transaction-based fees from clearinghouse operations, fiduciary in facilitating billions of dollars in healthcare transactions. By embedding itself as an essential cog in the healthcare revenue machinery, Waystar not only ensures its financial health but also sets the benchmark for technological advancement in an industry increasingly reliant on digital solutions.

WAY Intrinsic Value
25.07 USD
Overvaluation 32%
Intrinsic Value
Price
W

See Also

What is Waystar Holding Corp's Research & Development?
Research & Development
-35.3m USD

Based on the financial report for Dec 31, 2023, Waystar Holding Corp's Research & Development amounts to -35.3m USD.

What is Waystar Holding Corp's Research & Development growth rate?
Research & Development CAGR 1Y
-8%

Over the last year, the Research & Development growth was -8%.

Back to Top